Edmond de Rothschild Holding’s PHAXIAM Therapeutics S.A.. American Depositary Shares PHXM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-57
Closed -$12K 803
2018
Q1
$12K Hold
57
﹤0.01% 727
2017
Q4
$13K Buy
+57
New +$13.5K ﹤0.01% 736

Other funds holding PHXM

Edmond de Rothschild Holding's PHXM Position: Q2 2018 in Review

Edmond de Rothschild Holding sold out of PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) in Q2 2018, closing a stake of 57 shares — an estimated $12K sold.

Edmond de Rothschild Holding first reported a position in PHXM in Q4 2017 and held it in 2 quarters. The position peaked at $13K in Q4 2017. 7 funds tracked by Wall St. Rank hold PHXM as of Q2 2018.

  • Edmond de Rothschild Holding reported no remaining PHAXIAM Therapeutics S.A.. American Depositary Shares position as of Q2 2018 after selling out during the quarter.
  • Edmond de Rothschild Holding sold 57 PHAXIAM Therapeutics S.A.. American Depositary Shares shares in Q2 2018, an estimated $12K.
  • Edmond de Rothschild Holding first reported a position in PHAXIAM Therapeutics S.A.. American Depositary Shares in Q4 2017 and held it in 2 quarters.
  • Edmond de Rothschild Holding's PHAXIAM Therapeutics S.A.. American Depositary Shares position peaked at $13K in Q4 2017.
  • 7 funds tracked by Wall St. Rank held PHAXIAM Therapeutics S.A.. American Depositary Shares as of Q2 2018.

Based on Edmond de Rothschild Holding's 13F filing for Q2 2018, filed 14 Aug 2018.